Group 1 - The core stock price of Beishimei increased by 2.07% on November 19, reaching 9.86 CNY per share, with a total market capitalization of 3.561 billion CNY [1] - The company experienced a stock price decline of 3.43% year-to-date, but saw a 1.75% increase over the last five trading days and a 2.28% increase over the last 20 days, while it dropped 19.51% over the last 60 days [2] - As of September 30, the number of shareholders decreased by 9.41% to 18,000, with an average of 20,046 circulating shares per person, which increased by 10.39% [2] Group 2 - Beishimei's main business includes the research, production, and sales of products such as 4-nitro intermediates, dimethenamid-p active ingredients, and dimethenamid-p formulations, with the main revenue sources being dimethenamid-p active ingredients (25.95%) and various trade pesticides [2] - For the period from January to September 2025, Beishimei achieved operating revenue of 1.11 billion CNY, representing a year-on-year growth of 14.29%, and a net profit attributable to shareholders of 31.17 million CNY, reflecting a significant year-on-year increase of 1257.94% [2] - The company has distributed a total of 62.87 million CNY in dividends since its A-share listing, with 38.52 million CNY distributed over the past three years [3]

Core Points - The stock price of Hongyang fell by 2.08% on November 19, reaching 6.11 CNY per share, with a total market capitalization of 7.931 billion CNY [1] - The company has seen a year-to-date stock price increase of 2.35%, but has experienced declines of 3.17% over the last five trading days, 6.43% over the last twenty days, and 11.83% over the last sixty days [1] - Hongyang's main business involves the research and production of new environmentally friendly pesticides, with pesticide sales accounting for 96.95% of its revenue [1][2] Financial Performance - For the period from January to September 2025, Hongyang reported operating revenue of 2.328 billion CNY, a year-on-year decrease of 13.87%, and a net profit attributable to shareholders of -272 million CNY, a year-on-year decrease of 1115.05% [2] - The company has cumulatively distributed 1.146 billion CNY in dividends since its A-share listing, with no dividends distributed in the last three years [3] Shareholder Information - As of October 20, Hongyang had 43,300 shareholders, a decrease of 2.91% from the previous period, with an average of 22,852 circulating shares per shareholder, an increase of 2.99% [2]

Core Viewpoint - The stock of Yuanda Holdings has experienced fluctuations, with a year-to-date increase of 48.52% but a recent decline in the last 20 days by 20.48% [1][2] Group 1: Stock Performance - On November 17, Yuanda Holdings' stock price fell by 2.06%, trading at 8.54 CNY per share, with a total market capitalization of 4.327 billion CNY [1] - The stock has seen a trading volume of 2.32 billion CNY and a turnover rate of 5.30% [1] - Year-to-date, the stock has risen by 48.52%, with a recent 5-day increase of 2.77% and a 60-day increase of 22.88% [1] Group 2: Financial Performance - For the period from January to September 2025, Yuanda Holdings reported a revenue of 63.484 billion CNY, a year-on-year decrease of 4.68%, while the net profit attributable to shareholders increased by 142.30% to 32.181 million CNY [2] - The company has not distributed any dividends in the last three years, with a total payout of 195 million CNY since its A-share listing [3] Group 3: Shareholder Information - As of September 30, the number of shareholders for Yuanda Holdings was 22,500, an increase of 2.06% from the previous period [2] - The average number of circulating shares per shareholder decreased by 2.47% to 22,404 shares [2] Group 4: Business Overview - Yuanda Holdings is primarily engaged in bulk commodity trading, with 99.36% of its revenue coming from this sector, alongside minor contributions from crop science, specialty oils, and logistics [1]

11月17日，扬农化工盘中下跌2.00%，截至14:01，报67.97元/股，成交1.81亿元，换手率0.65%，总市值 275.55亿元。 资金流向方面，主力资金净流出761.55万元，特大单买入354.97万元，占比1.96%，卖出1091.46万元， 占比6.03%；大单买入4340.45万元，占比23.97%，卖出4365.51万元，占比24.11%。 扬农化工今年以来股价涨19.35%，近5个交易日涨1.03%，近20日跌0.64%，近60日涨5.05%。 资料显示，江苏扬农化工股份有限公司位于江苏省扬州市邗江区开发西路203号扬农大厦，成立日期 1999年12月10日，上市日期2002年4月25日，公司主营业务涉及农药产品的研发、生产和销售。主营业 务收入构成为：原药58.64%，贸易20.65%，制剂18.78%，其他1.93%。 扬农化工所属申万行业为：基础化工-农化制品-农药。所属概念板块包括：中化集团、草甘膦、生态农 业、股权转让、生物农药等。 截至9月30日，扬农化工股东户数1.69万，较上期减少6.49%；人均流通股23883股，较上期增加7.24%。 2025年1月-9月，扬农化工实 ...

Core Viewpoint - Jiangshan Co., Ltd. has shown a significant increase in stock price this year, with a 70.50% rise, despite a slight decline in recent trading days [1][2]. Financial Performance - For the period from January to September 2025, Jiangshan Co., Ltd. achieved a revenue of 4.516 billion yuan, representing a year-on-year growth of 5.20% [2]. - The net profit attributable to shareholders for the same period was 425 million yuan, marking a substantial increase of 147.91% year-on-year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 9.05% to 19,100, while the average circulating shares per person increased by 9.95% to 22,509 shares [2]. - The company has distributed a total of 2.693 billion yuan in dividends since its A-share listing, with 384 million yuan distributed over the past three years [3]. Stock Market Activity - On November 14, Jiangshan Co., Ltd. saw its stock price rise by 2.11%, reaching 23.70 yuan per share, with a trading volume of approximately 93.08 million yuan [1]. - The company’s market capitalization stands at 10.206 billion yuan, with a turnover rate of 0.93% [1]. Business Overview - Jiangshan Co., Ltd. primarily engages in the research, production, and sales of agricultural chemicals, including herbicides and insecticides, as well as chemical products and new materials [1]. - The revenue composition of the company includes 61.85% from agricultural products, 14.05% from chemical products, 13.95% from new materials, and 9.40% from thermal power products [1]. Institutional Holdings - As of September 30, 2025, major shareholders include China Europe Fund and Hong Kong Central Clearing Limited, with notable changes in their holdings [3].

11月14日，蓝丰生化盘中下跌2.06%，截至10:15，报9.05元/股，成交1.46亿元，换手率6.05%，总市值 32.18亿元。 资金流向方面，主力资金净流出1344.57万元，特大单买入105.20万元，占比0.72%，卖出384.94万元， 占比2.63%；大单买入1658.33万元，占比11.34%，卖出2723.15万元，占比18.62%。 蓝丰生化今年以来股价涨102.01%，近5个交易日涨2.49%，近20日涨7.23%，近60日涨65.75%。 今年以来蓝丰生化已经18次登上龙虎榜，最近一次登上龙虎榜为11月11日，当日龙虎榜净买入612.18万 元；买入总计1.74亿元 ，占总成交额比19.49%；卖出总计1.68亿元 ，占总成交额比18.81%。 资料显示，江苏蓝丰生物化工股份有限公司位于江苏新沂经济开发区宁夏路2号，成立日期1990年10月 11日，上市日期2010年12月3日，公司主营业务涉及杀菌剂原药及剂型、杀虫剂原药及剂型、除草剂原 药及剂型、精细化工中间体的生产和销售,医药制造板块业务。主营业务收入构成为：电池片43.84%， 组件31.70%，农药原药及制剂17.20%， ...

Core Insights - The stock price of Yuanda Holdings increased by 2.50% on November 14, reaching 8.62 CNY per share, with a total market capitalization of 4.367 billion CNY [1] - The company has seen a year-to-date stock price increase of 49.91%, with a recent 3.86% rise over the last five trading days [1] Financial Performance - For the period from January to September 2025, Yuanda Holdings reported a revenue of 63.484 billion CNY, a year-on-year decrease of 4.68%, while the net profit attributable to shareholders increased by 142.30% to 32.181 million CNY [2] - The company has cumulatively distributed 195 million CNY in dividends since its A-share listing, with no dividends distributed in the last three years [3] Stock Market Activity - The stock has appeared on the "Dragon and Tiger List" eight times this year, with the most recent appearance on October 23, where it recorded a net buy of -286.704 million CNY [1] - As of September 30, the number of shareholders increased to 22,500, with an average of 22,404 circulating shares per person, a decrease of 2.47% from the previous period [2] Business Overview - Yuanda Holdings is primarily engaged in bulk commodity trading, with 99.36% of its revenue coming from this sector, alongside minor contributions from crop science, specialty oils, and logistics [1][2]

Core Viewpoint - Limin Co., Ltd. has experienced significant stock price fluctuations and strong financial performance in 2023, with a notable increase in revenue and net profit, indicating potential growth opportunities in the agricultural chemicals sector [1][2]. Group 1: Stock Performance - As of November 14, Limin's stock price decreased by 2.00% to 19.59 CNY per share, with a trading volume of 1.52 billion CNY and a turnover rate of 1.92%, resulting in a total market capitalization of 8.699 billion CNY [1]. - Year-to-date, Limin's stock price has increased by 153.66%, with a 6.58% rise over the last five trading days and a 5.04% increase over the last 20 days, although it has declined by 9.52% over the last 60 days [1]. - The company has appeared on the "龙虎榜" (a trading board for stocks with significant trading activity) six times this year, with the most recent appearance on June 20, where it recorded a net purchase of 24.78 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Limin achieved a revenue of 3.599 billion CNY, representing a year-on-year growth of 7.62%, while the net profit attributable to shareholders reached 390 million CNY, marking a substantial increase of 661.66% [2]. - The company's main business revenue composition includes agricultural fungicides (50.57%), insecticides (30.51%), veterinary drugs (9.34%), herbicides (8.47%), and other products [1]. Group 3: Shareholder Information - As of October 31, the number of Limin's shareholders increased to 62,500, reflecting a rise of 12.55%, while the average number of circulating shares per shareholder decreased by 11.15% to 6,444 shares [2]. Group 4: Dividend Information - Since its A-share listing, Limin has distributed a total of 919 million CNY in dividends, with 321 million CNY distributed over the past three years [3].

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has shown significant stock performance, with a year-to-date increase of 154.18% and a recent rise of 2.03% in stock price [1] - As of November 13, the stock price reached 19.63 yuan per share, with a total market capitalization of 8.717 billion yuan [1] - The company has seen a net inflow of main funds amounting to 3.6133 million yuan, with large orders contributing significantly to the trading volume [1] Group 2 - Limin Co., Ltd. operates in the basic chemical industry, specifically in agricultural chemical products, including pesticides [2] - The company reported a revenue of 3.599 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 7.62%, while the net profit attributable to shareholders increased by 661.66% to 390 million yuan [2] - The company has a shareholder base of 62,500, which has increased by 12.55% compared to the previous period [2] Group 3 - Since its A-share listing, Limin Co., Ltd. has distributed a total of 919.8 million yuan in dividends, with 321 million yuan distributed over the past three years [3]

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 119.15%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 12, Baiao Chemical's stock price was 33.89 yuan per share, with a trading volume of 327 million yuan and a turnover rate of 1.40% [1]. - The company has appeared on the stock market's "Dragon and Tiger List" three times this year, with the most recent occurrence on August 28 [1]. Shareholder Information - As of September 30, the number of shareholders for Baiao Chemical increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Business Overview - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1]. - The company's revenue composition includes 54.95% from industrial biocides and 44.36% from semiconductors, with minor contributions from other segments [1].